pskG
    1.
    发明授权
    pskG 失效

    公开(公告)号:US06352840B1

    公开(公告)日:2002-03-05

    申请号:US09241750

    申请日:1999-02-01

    IPC分类号: C12P2106

    摘要: The invention provides pskG polypeptides and polynucleotides encoding pskG polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing pskG polypeptides to screen for antibacterial compounds.

    摘要翻译: 本发明提供了pskG多肽和编码pskG多肽的多核苷酸以及通过重组技术产生这种多肽的方法。 还提供了利用pskG多肽筛选抗菌化合物的方法。

    Compounds and methods for the treatment of neoplastic disease
    3.
    发明授权
    Compounds and methods for the treatment of neoplastic disease 有权
    用于治疗肿瘤性疾病的化合物和方法

    公开(公告)号:US06803369B1

    公开(公告)日:2004-10-12

    申请号:US09912483

    申请日:2001-07-25

    IPC分类号: A61K31497

    CPC分类号: C07D401/06 A61K31/497

    摘要: A method of modulating the activity of a aberrant cell topoisomerase enzyme involving contacting the enzyme with a compound that inhibits enzyme-mediated cleavage of a polynucleotide substrate with which the enzyme is in complex. Pharmaceutical compositions containing such compounds may be used to treat neoplasias or to inhibit the growth of certain cancer cells. Screening methods can be employed to identify other compounds for these uses.

    摘要翻译: 调节异常细胞拓扑异构酶的活性的方法,包括使酶与抑制酶介导的酶复合物的多核苷酸底物的酶介导的切割的化合物接触。 含有这些化合物的药物组合物可用于治疗肿瘤或抑制某些癌细胞的生长。 可以使用筛选方法来鉴定用于这些用途的其它化合物。